CSTONE PHARMA-B (02616) completes the placement of 100 million shares of placement shares.
Jichishiyao Pharmaceutical-B (02616) announced that all conditions for the placement have been met, and the placement was completed on July 1, 2025.
CSTONE PHARMA-B (02616) announces that all conditions of the placement have been met and the placement was completed on July 16, 2025. According to the terms of the placement agreement, 100 million shares of placement shares have been successfully placed by the placement agent to at least six underwriters at a placement price of HK$4.72 per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
